Vietnam Branded Generics Market Report Size, Share, Growth Drivers, Trends, Opportunities And Forecast 2025–2030

Vietnam Branded Generics Market Overview

• The Vietnam Branded Generics Market is valued at USD 1.0 billion, based on a five-year historical analysis. This growth is primarily driven by the increasing demand for affordable healthcare solutions, rising prevalence of chronic diseases such as diabetes, hypertension, and cardiovascular conditions, and a growing middle-class population seeking quality medications. The market is also supported by the government's initiatives to promote local pharmaceutical manufacturing and reduce dependency on imported drugs.
• Key cities such as Ho Chi Minh City and Hanoi dominate the market due to their large populations, advanced healthcare infrastructure, and concentration of pharmaceutical companies. These urban centers serve as hubs for distribution and innovation, attracting investments and fostering competition among local and international players.
• The Circular 21/2018/TT-BYT issued by the Ministry of Health in 2018 regulates the quality management and marketing authorization of drugs, including generics. This regulation requires all branded generics to meet Good Manufacturing Practice standards, undergo bioequivalence testing for certain products, and obtain registration certificates specifying active ingredients, dosage forms, and therapeutic indications before market approval.

Vietnam Branded Generics Market Segmentation

By Drug Type:The market is segmented into two primary categories: Pure Generic Drugs and Branded Generics. Pure Generic Drugs are typically less expensive alternatives to brand-name medications, while Branded Generics are marketed under a brand name but contain the same active ingredients as their generic counterparts. The Branded Generics segment is currently leading the market due to increasing consumer trust in branded products and the perception of higher quality.

By Route of Administration:The market is further divided based on the route of administration, which includes Oral, Parenteral (Injectables), Topical, Inhalation, and Others. The Oral segment dominates the market due to the convenience and ease of administration associated with oral medications. This preference is driven by consumer behavior favoring non-invasive treatment options and the wide availability of oral formulations.

Vietnam Branded Generics Market Competitive Landscape

The Vietnam Branded Generics Market is characterized by a dynamic mix of regional and international players. Leading participants such as DHG Pharmaceutical, Traphaco, Imexpharm, OPC Pharmaceutical, SPM Pharmaceutical, Vimedimex, Sanofi Vietnam, Pfizer Vietnam, Merck Sharp & Dohme (MSD) Vietnam, Novartis Vietnam, GlaxoSmithKline (GSK) Vietnam, AstraZeneca Vietnam, Roche Vietnam, Johnson & Johnson Vietnam, Bayer Vietnam contribute to innovation, geographic expansion, and service delivery in this space.

Vietnam Branded Generics Market Industry Analysis

Growth Drivers

• Increasing Healthcare Expenditure:Vietnam's healthcare expenditure is projected to reach approximately 7.5% of GDP in the future, translating to around 25 billion USD. This increase is driven by government initiatives to enhance healthcare infrastructure and services. The rising investment in healthcare facilities and services is expected to boost the demand for branded generics, as more patients seek affordable treatment options. This trend aligns with the government's commitment to improving public health outcomes and access to medications.
• Rising Prevalence of Chronic Diseases:The World Health Organization reported that chronic diseases account for 75% of all deaths in Vietnam, with conditions like diabetes and cardiovascular diseases on the rise. In the future, it is estimated that over 20 million people will be living with chronic diseases, significantly increasing the demand for effective and affordable medications. This growing patient population is driving the need for branded generics, which offer cost-effective alternatives to expensive branded drugs, thereby enhancing treatment accessibility.
• Expanding Health Insurance Coverage:In the future, Vietnam aims to achieve 90% health insurance coverage among its population, up from 86% in the recent past. This expansion is expected to facilitate greater access to healthcare services and medications, including branded generics. With more individuals insured, the demand for affordable medications will rise, as patients will seek cost-effective treatment options that are covered by their insurance plans, thereby driving growth in the branded generics market.

Market Challenges

• Intense Competition from Multinational Companies:The Vietnamese branded generics market faces significant competition from multinational pharmaceutical companies, which hold a substantial market share. In the future, it is estimated that these companies will account for over 60% of the market, leveraging their established brands and extensive distribution networks. This competition poses a challenge for local manufacturers, who must innovate and differentiate their products to capture market share and remain competitive in pricing and quality.
• Regulatory Hurdles and Compliance Issues:The regulatory landscape in Vietnam is complex, with stringent requirements for drug approval and quality control. In the future, the Ministry of Health is expected to implement even stricter regulations, which may increase the time and cost associated with bringing new branded generics to market. Compliance with these regulations can be challenging for local manufacturers, potentially hindering their ability to compete effectively against larger multinational firms that have more resources to navigate these hurdles.

Vietnam Branded Generics Market Future Outlook

The future of the Vietnam branded generics market appears promising, driven by increasing healthcare investments and a growing patient population with chronic diseases. As health insurance coverage expands, more consumers will seek affordable medication options, further propelling market growth. Additionally, the trend towards personalized medicine and digital health solutions is expected to reshape the market landscape, encouraging innovation and enhancing patient engagement. Local manufacturers must adapt to these trends to capitalize on emerging opportunities and maintain competitiveness in a dynamic environment.

Market Opportunities

• Expansion into Rural Markets:With approximately 70% of Vietnam's population residing in rural areas, there is a significant opportunity for branded generics to penetrate these underserved markets. In the future, targeted distribution strategies and partnerships with local healthcare providers can enhance access to affordable medications, addressing the healthcare disparities faced by rural populations and driving sales growth in these regions.
• Investment in Digital Health Solutions:The digital health market in Vietnam is projected to grow significantly, with investments expected to reach 1.5 billion USD in the future. This presents an opportunity for branded generics to leverage telemedicine and e-pharmacy platforms to reach consumers more effectively. By integrating digital solutions, companies can enhance patient engagement, streamline distribution, and improve access to medications, ultimately driving market growth.